Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-31 @ 11:10 AM
Study NCT ID:
NCT07360132
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-01-22
First Post:
2026-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer
Sponsor:
Shanghai Huaota Biopharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-04-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-10
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-13
First Submit QC Date:
None
Study First Post Date:
2026-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-01-13
Last Update Post Date:
2026-01-22
Last Update Post Date Type:
ACTUAL